Your browser doesn't support javascript.
loading
Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.
Yi, Zong-Bi; Yu, Pei; Zhang, Su; Wang, Wen-Na; Han, Yi-Qun; Ouyang, Qu-Chang; Yan, Min; Wang, Xiao-Jia; Hu, Xi-Chun; Jiang, Ze-Fei; Huang, Tao; Tong, Zhong-Sheng; Wang, Shu-Sen; Yin, Yong-Mei; Li, Hui; Yang, Run-Xiang; Yang, Hua-Wei; Teng, Yue-E; Sun, Tao; Cai, Li; Li, Hong-Yuan; Chen, Xi; He, Jian-Jun; Liu, Xin-Lan; Yang, Shun-E; Wang, Jia-Yu; Fan, Jin-Hu; Qiao, You-Lin; Xu, Bing-He.
  • Yi ZB; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Yu P; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhang S; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang WN; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Han YQ; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Ouyang QC; Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, China.
  • Yan M; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Wang XJ; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Hu XC; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Jiang ZF; Department of Breast Cancer, The Fifth Medical Centre of Chinese PLA General Hospital, Beijing, China.
  • Huang T; Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Tong ZS; Department of Breast Oncology, Key Laboratory of Breast Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Wang SS; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yin YM; Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Li H; Department of Breast Surgery, Sichuan Province Tumor Hospital, Chengdu, Sichuan, China.
  • Yang RX; Department of Medical Oncology, Yunnan Cancer Hospital, Kunming Medical University, Kunming, China.
  • Yang HW; Department of Breast Surgery, Cancer Hospital, Guangxi Medical University, Guangxi, China.
  • Teng YE; Departments of Medical Oncology and Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China.
  • Sun T; Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Key Laboratory of Liaoning Breast Cancer Research, Shenyang, China.
  • Cai L; The 4th Department of Internal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Li HY; Department of the Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.
  • Chen X; Department of Medicine Oncology, 900 Hospital of the Joint Logistics Team, Fuzhou, China.
  • He JJ; Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Liu XL; Department of Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Yang SE; Department of Breast Cancer and Lymphoma, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China.
  • Wang JY; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Fan JH; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Qiao YL; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Xu BH; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Int J Cancer ; 148(3): 692-701, 2021 02 01.
Article en En | MEDLINE | ID: mdl-32700765
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Progesterona / Receptores de Estrógenos / Receptor ErbB-2 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Progesterona / Receptores de Estrógenos / Receptor ErbB-2 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans Idioma: En Año: 2021 Tipo del documento: Article